{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.8","upperLimit":"28","value":"7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"}],"units":"Participants"}],"description":"Overall Survival is defined as the number of days from the day the subject started treatment to the day the subject experienced death or lost to follow-up.","dispersionType":"Full Range","groups":[{"description":"Zometa (zoledronic acid) will be administered by infusion on Day 1 of a 3-week cycle followed by tumor assessment from CT and/or PET scans every 2 cycles. This will continue until progression of disease and/or intolerable toxicity.\n\nZometa: Zoledronic acid will be administered IV on the first day of a 21 day cycle at a concentration of 4 mg. The treatment will take about 30-60 minutes with the infusion lasting about 15 minutes.","id":"OG000","title":"Zometa"}],"paramType":"MEDIAN","populationDescription":"Participants with advanced malignant pleural mesothelioma.","reportingStatus":"POSTED","timeFrame":"Baseline up to 28 months","title":"Overall Survival (OS)","type":"SECONDARY","unitOfMeasure":"months"}